Cargando…
Review of Anti-inflammatory and Antiviral Therapeutics for Hospitalized Patients Infected with Severe Acute Respiratory Syndrome Coronavirus 2
Severe acute respiratory syndrome coronavirus 2 infection leads to dysregulation of immune pathways. Therapies focusing on suppressing cytokine activity have some success. Current evidence supports the use of dexamethasone in hospitalized patients requiring oxygen to decrease mortality. Interleukin-...
Autores principales: | Chen, Jen-Ting, Ostermann, Marlies |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841241/ https://www.ncbi.nlm.nih.gov/pubmed/35667745 http://dx.doi.org/10.1016/j.ccc.2022.02.002 |
Ejemplares similares
-
Clinical severe acute respiratory syndrome coronavirus 2 isolation and antiviral testing
por: Mathez, Gregory, et al.
Publicado: (2021) -
Delayed Antiviral Immune Responses in Severe Acute Respiratory Syndrome Coronavirus Infected Pregnant Mice
por: Zhu, Guohua, et al.
Publicado: (2022) -
Antiviral drugs against severe acute respiratory syndrome coronavirus 2 infection triggering the coronavirus disease-19 pandemic
por: Noor, Rashed
Publicado: (2020) -
Antiviral efficacy of personal care formulations against Severe Acute Respiratory Syndrome Coronavirus 2
por: Mukherjee, Sayandip, et al.
Publicado: (2021) -
Long-term positive severe acute respiratory syndrome coronavirus 2 ribonucleic acid and therapeutic effect of antivirals in patients with coronavirus disease: Case reports
por: Wei, Bo, et al.
Publicado: (2020)